Literature DB >> 20932800

p53 post-translational modification: deregulated in tumorigenesis.

Chao Dai1, Wei Gu.   

Abstract

The p53 tumor suppressor protein has well-established roles in monitoring various types of stress signals by activating specific transcriptional targets that control cell cycle arrest and apoptosis, although some activities are also mediated in a transcription-independent manner. Here, we review the recent advances in our understanding of the wide spectrum of post-translational modifications that act as epigenetic-like codes for modulating specific functions of p53 in vivo and how deregulation of these modifications might contribute to tumorigenesis. We also discuss future research priorities to further understand p53 post-translational modifications and the interpretation of genetic data in appreciation of the increasing evidence that p53 regulates cellular metabolism, autophagy and many unconventional tumor suppressor activities.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932800      PMCID: PMC2978905          DOI: 10.1016/j.molmed.2010.09.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  95 in total

1.  Acetylation is indispensable for p53 activation.

Authors:  Yi Tang; Wenhui Zhao; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

2.  SnapShot: p53 posttranslational modifications.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

3.  Regulation of autophagy by cytoplasmic p53.

Authors:  Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2008-05-04       Impact factor: 28.824

Review 4.  Protein methylation: a new mechanism of p53 tumor suppressor regulation.

Authors:  A Scoumanne; X Chen
Journal:  Histol Histopathol       Date:  2008-09       Impact factor: 2.303

5.  DBC1 is a negative regulator of SIRT1.

Authors:  Ja-Eun Kim; Junjie Chen; Zhenkun Lou
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

6.  Negative regulation of the deacetylase SIRT1 by DBC1.

Authors:  Wenhui Zhao; Jan-Philipp Kruse; Yi Tang; Sung Yun Jung; Jun Qin; Wei Gu
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

7.  The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts.

Authors:  Wendy Bruins; Oskar Bruning; Martijs J Jonker; Edwin Zwart; Tessa V van der Hoeven; Jeroen L A Pennings; Han Rauwerda; Annemieke de Vries; Timo M Breit
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

8.  A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice.

Authors:  Jamie L Barger; Tsuyoshi Kayo; James M Vann; Edward B Arias; Jelai Wang; Timothy A Hacker; Ying Wang; Daniel Raederstorff; Jason D Morrow; Christiaan Leeuwenburgh; David B Allison; Kurt W Saupe; Gregory D Cartee; Richard Weindruch; Tomas A Prolla
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

9.  Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.

Authors:  Sonia Lain; Jonathan J Hollick; Johanna Campbell; Oliver D Staples; Maureen Higgins; Mustapha Aoubala; Anna McCarthy; Virginia Appleyard; Karen E Murray; Lee Baker; Alastair Thompson; Joanne Mathers; Stephen J Holland; Michael J R Stark; Georgia Pass; Julie Woods; David P Lane; Nicholas J Westwood
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

10.  The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.

Authors:  Ron Firestein; Gil Blander; Shaday Michan; Philipp Oberdoerffer; Shuji Ogino; Jennifer Campbell; Anupama Bhimavarapu; Sandra Luikenhuis; Rafael de Cabo; Charles Fuchs; William C Hahn; Leonard P Guarente; David A Sinclair
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

View more
  227 in total

1.  Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.

Authors:  Kenzo Ohara; Takayuki Ohkuri; Takumi Kumai; Toshihiro Nagato; Yui Nozaki; Kei Ishibashi; Akemi Kosaka; Marino Nagata; Shohei Harabuchi; Mizuho Ohara; Kensuke Oikawa; Naoko Aoki; Yasuaki Harabuchi; Esteban Celis; Hiroya Kobayashi
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

2.  Zinc proteome interaction network as a model to identify nutrient-affected pathways in human pathologies.

Authors:  Guido Leoni; Antonio Rosato; Giuditta Perozzi; Chiara Murgia
Journal:  Genes Nutr       Date:  2014-11-04       Impact factor: 5.523

3.  Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90.

Authors:  Chao Dai; Yi Tang; Sung Yun Jung; Jun Qin; Stuart A Aaronson; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

4.  Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.

Authors:  Lorna Jane Warnock; Sally Anne Raines; Jo Milner
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

5.  Get your fingers out of p53's way!

Authors:  Débora Rosa Bublik; Moshe Oren
Journal:  EMBO Rep       Date:  2012-04-02       Impact factor: 8.807

Review 6.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

7.  cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.

Authors:  Rosanna Lau; Min Ying Niu; M A Christine Pratt
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

8.  HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation.

Authors:  Jing Qi; Sandeep Singh; Wei-Kai Hua; Qi Cai; Shi-Wei Chao; Ling Li; Hongjun Liu; Yinwei Ho; Tinisha McDonald; Allen Lin; Guido Marcucci; Ravi Bhatia; Wei-Jan Huang; Chung-I Chang; Ya-Huei Kuo
Journal:  Cell Stem Cell       Date:  2015-09-18       Impact factor: 24.633

9.  Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress.

Authors:  Jonathan Chang; Brandi N Davis-Dusenbery; Risa Kashima; Xuan Jiang; Nisha Marathe; Roberto Sessa; Justin Louie; Wei Gu; Giorgio Lagna; Akiko Hata
Journal:  EMBO J       Date:  2013-11-12       Impact factor: 11.598

10.  Microchip-Based Structure Determination of Disease-Relevant p53.

Authors:  Maria J Solares; G M Jonaid; William Y Luqiu; Yanping Liang; Madison C Evans; William J Dearnaley; Zhi Sheng; Deborah F Kelly
Journal:  Anal Chem       Date:  2020-10-30       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.